Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Gross Profit (2020 - 2025)

Abeona Therapeutics (ABEO) has 8 years of Gross Profit data on record, last reported at $300000.0 in Q2 2025.

  • For Q2 2025, Gross Profit changed N/A year-over-year to $300000.0; the TTM value through Jun 2025 reached $2.2 million, changed N/A, while the annual FY2023 figure was $1.9 million, 96.58% up from the prior year.
  • Gross Profit reached $300000.0 in Q2 2025 per ABEO's latest filing, up from -$30000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $1.9 million in Q2 2023 and bottomed at -$32000.0 in Q4 2022.
  • Average Gross Profit over 3 years is $562600.0, with a median of $300000.0 recorded in 2025.
  • The widest YoY moves for Gross Profit: up 196.15% in 2023, down 196.15% in 2023.
  • A 3-year view of Gross Profit shows it stood at -$32000.0 in 2022, then rose by 6.25% to -$30000.0 in 2023, then skyrocketed by 1100.0% to $300000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $300000.0 in Q2 2025, -$30000.0 in Q3 2023, and $1.9 million in Q2 2023.